Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM – nejm.org
Business News
- Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM nejm.org
- Drug in limited trials against COVID-19 CGTN America
- Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine Business Wire
- Mayo Clinic plans pay cuts in face of massive loss MinnPost
- View Full Coverage on Google News
Source: Business News